MUST READS AND LISTEN

A September 4, 2015 NPR.org All Things Considered segment reported on an experimental Alzheimer’s drug from Japan’s Toyama Chemical Company that tests a new approach to fighting the disease. According to the transcript, “A new experimental drug is designed to slow down Alzheimer's by protecting brain cells from toxins associated with the disease. That's a different approach from other Alzheimer's drugs, which have tried to eliminate those toxins.”

A September 4, 2015 U.S. News & World Report article highlighted the importance of helping dementia sufferers by "illuminating their place in this world". According to the article, “When our loved ones cannot remember, let us remember and help comfort them by illuminating their place in this world. The theme for this year’s World Alzheimer’s Month is “Remember Me”. Launched by Alzheimer’s Disease International, or ADI, four years ago, World Alzheimer’s Month was ignited to encourage people to learn about dementia – such as how to spot the signs – while not forgetting about loved ones who are living with or have died from the disease. UK-based ADI is the international umbrella organization representing Alzheimer’s organizations worldwide.”

RESEARCH, SCIENCE, AND TECHNOLOGY 

A September 6, 2015 The San Diego-Union Tribune article reported that “A genetic signature predictive of Alzheimer’s has been identified by the researchers, who say it could be turned into a test to identify those at high risk.”

A September 5, 2015 Medical News Today article reported that “A new study indicates that a drug may represent a novel therapeutic target for Alzheimer's disease after researchers used it to treat the disease in rats.”

A September 4, 2015 Las Vegas Review-Journal article reported that “UNLV and the Cleveland Clinic Lou Ruvo Center for Brain Health have been awarded an $11.1 million federal grant to advance the understanding of Alzheimer's and Parkinson's diseases.”